FT Cboe Vest U.S. Equity Enhance & Moderate… (XNOV) Performance
XNOV total return
Distributions reinvested · as of Oct 23, 2026- YTD
- +7.2% since Dec 31, 2025
- 1 year
- +10.3% total return
- Since first price
- +32.0% since 2023
XNOV trailing returns vs SPY, QQQ, AGG
| Period | XNOV total return | Price only | S&P 500 (SPY) | Nasdaq-100 (QQQ) | U.S. bonds (AGG) |
|---|---|---|---|---|---|
| 1 month | +0.6% | +0.6% | −1.0% | −5.0% | +0.9% |
| 3 months | +2.4% | +2.4% | +3.2% | +1.9% | −0.4% |
| 6 months | +4.9% | +4.9% | +7.8% | +8.4% | −1.5% |
| YTD | +7.2% | +7.2% | +12.3% | +15.1% | −1.0% |
| 1 year | +10.3% | +10.3% | +14.4% | +15.9% | −1.1% |
| Since inceptionNov 20, 2023 | +32.0% | +32.0% | — | — | — |
Total return from adjusted closes (distributions reinvested, before tax). Periods of 3 years or more are also shown annualized. Price only excludes distributions.
Growth of $10,000: XNOV vs SPY
From Nov 20, 2023: XNOV grew to $13,200, SPY to $17,347.
Year-end values with distributions reinvested, no taxes or trading costs. Start: first common trading day of both funds.
XNOV returns by calendar year
2 of 2 full years positive. Best 2025 (+11.3%), worst 2024 (+8.3%). 2026 is year to date.
XNOV annual returns table
| Year | XNOV | Largest drop | SPY | QQQ | AGG |
|---|---|---|---|---|---|
| 2026YTD | +7.2% | −3.6% | +12.3% | +15.1% | −1.0% |
| 2025 | +11.3% | −10.0% | +17.7% | +20.8% | +7.2% |
| 2024 | +8.3% | −1.9% | +24.9% | +25.6% | +1.3% |
Largest drop = deepest fall from a high within that calendar year.
Calendar-year return vs largest drop within the year
Most years include a sizable fall at some point even when the year ends higher.
XNOV risk statistics
| Statistic | Since 2023 |
|---|---|
| Annualized return | +10.0% |
| Volatility (annualized) | 4.2% |
| Sharpe ratio | 1.28 |
| Sortino ratio | 2.40 |
| Best month | +4.1% |
| Worst month | −2.3% |
| Best 12 months | +16.0% |
| Worst 12 months | +3.9% |
| Positive months | 82% |
| Beta vs S&P 500 | — |
| Correlation with S&P 500 | — |
From monthly total returns. Sharpe and Sortino use 1–3 month T-bills (BIL) as the risk-free rate, so they need history from 2007 on.
XNOV rolling returns
| Holding period | Periods | Worst | Median | Best | Positive |
|---|---|---|---|---|---|
| 1-year | 24 | +3.9% | +9.8% | +16.0% | 100% |
Every holding period starting at a month-end since 2023. Returns for 3 years and longer are annualized.
XNOV performance overview
FT Cboe Vest U.S. Equity Enhance & Moderate… (XNOV) returned +10.3% over the past year, with distributions reinvested. Since its first recorded price on Nov 20, 2023 it has returned +32.0%. Over the same year S&P 500 (SPY) returned +14.4%.
Related: XNOV chart. See the XNOV overview for the latest quote and fund facts.
XNOV performance FAQ
What is the XNOV return over the past year?
XNOV returned +10.3% over the 12 months to October 23, 2026, including reinvested distributions. On price alone it rose 10.3%.
How much would $10,000 invested in XNOV be worth?
$10,000 invested in XNOV at its first recorded close on November 20, 2023 would be worth about $13,200 on October 23, 2026 with distributions reinvested.
What was the worst year for XNOV?
The worst calendar year was 2024, with a total return of +8.3%. The best was 2025 at +11.3%.
How volatile is XNOV?
Over the past history XNOV had an annualized volatility of 4.2% and a Sharpe ratio of 1.28 (excess return over 1–3 month T-bills per unit of risk).